<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="1438">
  <stage>Registered</stage>
  <submitdate>29/06/2006</submitdate>
  <approvaldate>5/07/2006</approvaldate>
  <actrnumber>ACTRN12606000281594</actrnumber>
  <trial_identification>
    <studytitle>Infant fish oil study</studytitle>
    <scientifictitle>The immunomodulatory effects of omega-3 polyunsaturated fatty acids : role in allergy prevention</scientifictitle>
    <utrn />
    <trialacronym>IFOS</trialacronym>
  </trial_identification>
  <conditions>
    <healthcondition>Allergic disease</healthcondition>
    <conditioncode>
      <conditioncode1>Inflammatory and Immune System</conditioncode1>
      <conditioncode2>Allergies</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Children will be randomised to receive n-3 rich fish oil (280mg docosahexanoic acid [DHA]/day; 110mg eicosapentanoic acid [EPA]/day orally; Meg 3 Ocean Nutrition, Canada) daily for the first 6 months of life. 

The capsules are identical in appearance. Peppermint flavour has been added to both fish oil  and placebo capsules.</interventions>
    <comparator>Placebo (olive oil, Ocean Nutrition, Canada) daily for the first 6 months of life.</comparator>
    <control>Placebo</control>
    <interventioncode>Prevention</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Allergic sensitisation</outcome>
      <timepoint>Assessed at 1, 2.5 and 5 years of age</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Allergic disease</outcome>
      <timepoint>Assessed at 1, 2.5 and 5 years of age</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Effects on immune development</outcome>
      <timepoint>At 6 and 12 months of age.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria> 1) maternal asthma or hayfever, and atopy confirmed by skin testing (to common allergens); and 2) maternal age</inclusivecriteria>
    <inclusiveminage>0</inclusiveminage>
    <inclusiveminagetype>Not stated</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>Not stated</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Infants will be excluded if:  1) their mothers normal dietary intake exceeds 2 meals of fish per week 2) there are any significant pregnancy or neonatal complications including prematurity of &lt; 36 weeks), or 3) parental smoking.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Prevention</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Allocation was concealed and  involved contacting the holder of the allocation schedule who was "off-site".</concealment>
    <sequence>Eligible infants will be stratified by type of maternal atopy (asthma / other allergy), paternal atopic history and parity, and randomised to placebo or treatment groups. This will be performed by staff who are not involved in clinical or laboratory assessments.</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Single group</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 2</phase>
    <anticipatedstartdate>1/06/2005</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>360</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Prof Susan Prescott</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
    <fundingsource>
      <fundingtype>Government body</fundingtype>
      <fundingname>NHMRC</fundingname>
      <fundingaddress />
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>Commercial sector/Industry</fundingtype>
      <fundingname>VRI Biomedical</fundingname>
      <fundingaddress />
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>University</sponsortype>
      <sponsorname>University of Western Australia</sponsorname>
      <sponsoraddress />
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>In this study we will compare the effects of fish oil (n=165) or placebo (n=165) in early infancy (from 0-6 months of age) on the risk of developing allergic sensitisation or allergic disease in early childhood. Both study groups will include children deemed to be at high risk of allergic disease (based on maternal allergy history).</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Princess Margaret Hospital</ethicname>
      <ethicaddress />
      <ethicapprovaldate>21/04/2005</ethicapprovaldate>
      <hrec>1111/EP</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Dr Jan Dunstan</name>
      <address>School of Paediatrics and Child Health 
Princess Margaret Hospital
Subiaco  6008 WA</address>
      <phone>(618) 9388 8681</phone>
      <fax>(618) 9388 2097</fax>
      <email>susanp@ichr.uwa.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Prof Susan Prescott</name>
      <address>School of Paediatrics and Child Health 
Princess Margaret Hospital
Subiaco, 6008 WA</address>
      <phone>(618) 9340 8171</phone>
      <fax>(618) 9388 2097</fax>
      <email>susanp@ichr.uwa.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>